Biomarker for Cystic Fibrosis
NCT02710383 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 54
Last updated 2023-02-10
Summary
International, multicenter, observational, longitudinal study to identify biomarker/s for Cystic fibrosis and to explore the clinical robustness, specificity, and long-term variability of these biomarker/s
Conditions
- Chronic Nasal Congestion
- Lung Infection
- Breathlessness
- Clubbing Toes
- Meconium Ileus
- Failure to Thrive
- Pancreatitis
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. Dr. · Centogene GmbH
Eligibility
- Min Age
- 2 Months
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- Albania
- Georgia
- India
- Pakistan
- Sri Lanka
Study Locations
More Related Trials
-
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
NCT01805713 ·Status: COMPLETED
-
Costimulatory Molecules as Biomarkers in Cystic Fibrosis
NCT01353950 ·Status: COMPLETED
-
Non-Invasive Biomarkers in Cystic Fibrosis
NCT00413140 ·Status: COMPLETED
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation
NCT00788359 ·Status: COMPLETED
-
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
NCT06296394 ·Status: RECRUITING
-
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
NCT01543620 ·Status: UNKNOWN
-
Genetic Modifiers of Cystic Fibrosis: Sibling Study
NCT00037778 ·Status: COMPLETED
-
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies
NCT00727285 ·Status: COMPLETED
-
Registry Study on Cystic Fibrosis in Chinese Children
NCT02753374 ·Status: NOT_YET_RECRUITING
-
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
NCT02769637 ·Status: TERMINATED
-
Tissue Collection From People With Cystic Fibrosis
NCT00015756 ·Status: COMPLETED
-
Asthma With Hypersecretion-associated Gene for Cystic Fibrosis
NCT02558127 ·Status: COMPLETED
-
Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects
NCT02603666 ·Status: COMPLETED ·Phase: NA
-
Gene Modifiers of Cystic Fibrosis Lung Disease
NCT00037765 ·Status: ACTIVE_NOT_RECRUITING
-
Longitudinal Analysis of Respiratory and Intestinal Microbiome in Cystic Fibrosis
NCT03335202 ·Status: UNKNOWN
-
Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations
NCT00381628 ·Status: COMPLETED
-
Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects
NCT01078740 ·Status: COMPLETED
-
A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease
NCT00311506 ·Status: COMPLETED
-
Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis
NCT05604495 ·Status: RECRUITING
-
Cystic Fibrosis Diagnosis by Analyzing Nasal Brushing
NCT02433132 ·Status: UNKNOWN ·Phase: NA
-
Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis
NCT01347190 ·Status: COMPLETED ·Phase: PHASE1
-
Cystic Fibrosis Related Bone Disease: the Role of CFTR
NCT01549314 ·Status: COMPLETED
-
A Study to Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, and ABBV-576 in Healthy Adults for the Treatment of Cystic Fibrosis
NCT05530278 ·Status: COMPLETED ·Phase: PHASE1
-
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF
NCT05639556 ·Status: ACTIVE_NOT_RECRUITING